Eli Lilly announced clinical trial results for retatrutide, its next gen obesity drug. The drug helped study participants lose 70 lbs over 80 weeks, making it more powerful than Zepbound and Wegovy.
CBS Radio signs off for the last time Friday night, after almost a century that helped define broadcast news. Copyright 2026 NPR ...
With a dash of sci-fi, Colbert ended his CBS late-night show with a powerful musical sendoff featuring Paul McCartney, Elvis ...
Republicans struggled Thursday to find the votes to dismiss legislation that would compel President Donald Trump to withdraw ...
President Donald Trump and America's top diplomat on Thursday again raised the specter of U.S. military intervention in Cuba, ...
President Trump’s ‘Big Beautiful Bill,’ also known as H.R. 1, is redefining work and age requirements for recipients of ...
Kyle Busch, who won more races than anyone across NASCAR's three national series, has died at 41. A joint statement from the ...
In a rare rebuke, Senate Republicans postponed a vote to fund immigration enforcement amid alarm over the novel fund ...
The Palestinian delegation to the United Nations has dropped its bid to secure a top U.N. job after the U.S. threatens to ...
In Washington state and Hawaii, residents can now get mifepristone and misoprostol from Planned Parenthood to keep in their ...
Byrne is one of the few actors to receive both an Oscar and a Tony nomination in the same year —for the indie film If I Had ...
Forecasters expect 8 to 14 storms will form in the Atlantic between June 1 and November 30. But the danger is more serious ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results